[ DBS System raises $2.52M in Series A funding ]

DBS System has raised $2.52 million in Series A funding.

Founded in 2010, DBS System  is a meditech startup that offers a range of drug screening, biomarker detection, and genetic testing services to its clients. DBS System launched its first product HemaXis DB for whole blood collection at the end of 2015 with sales to pharmaceutical companies and research hospital labs who tested and developed protocols for the analysis that would be run on the blood samples collected by the device.

With this investment, DBS System will industrialize its second generation HemaXis blood collection device.

Funding  Series A
Founded  2010
Country  Switzerland
City  Geneva
Founder / CEO  Eric Ödman
Deal Size  $2.52M
Investors  Nest Collective Foundation
 investiere | Verve Capital Partners  AG
Previous Investors  /

[adyen action=”checkout_button”]